menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now
ReachMD Faculty

Public Profile

Alan S. Brown, MD, FNLA
Alan S. Brown, MD, FNLA
    Program NameLast Air DateHosts/Guests
    Meet Alan Brown, MD
    Treating Erectile Dysfunction: Key Cardiovascular Considerations10/16/2017
    Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?10/02/2017
    Triglyceride-Lowering Therapies: Addressing Gaps in the Guidelines09/04/2017
    PCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects12/12/2017
    Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease09/11/2017
    Canadian Perspectives on Managing Lipid Disorders in Children09/26/2017
    Lipid-Lowering Drug Interactions in Cardiovascular Agents12/04/2017
    Selecting the Right Contraception for the Dyslipidemic Woman11/24/2017
    Lipidologists Confronting the Obesity Epidemic: Perspectives from NLA President Joyce Ross11/28/2017
    Big Data in Lipids: Refining Cardiovascular Risk Profiles Nationwide 10/23/2017
    Cardiovascular Risk Reduction in the Elderly: Best Lipid Strategies11/14/2017
    What's the Deal with Saturated Fat and Cardiovascular Disease Risk?11/06/2017
    Lipidology's Advances and Growing Pains: Technologies, Drug Trials, and Guidelines11/16/2017
    The Lipidology Essentials: Making of a Specialty's Annual Summary11/20/2017
    Clinical Decisions on Cardiovascular Disease: Are Risks or Causes Your Guide?10/12/2017
    Pathways Toward Better Lipid Medication Adherence12/07/2017
    Special Populations in Patient-Centered Management of Dyslipidemia08/09/2017
    Dyslipidemia in The Elderly: How Old is "Too Old" to Treat? 08/03/2017
    Guidelines for Diagnosis and Management of Dyslipidemia in Patients with HIV08/23/2017
    Updated NLA Recommendations for African American Patients11/29/2017
    Dyslipidemia in Children and Adolescents08/10/2017
    Million Hearts Initiative with Dr. Janet Wright, Executive Director08/31/2017
    Dyslipidemia During Pregnancy: The Risks for Two Patients09/08/2017
    Statin Intolerance: Keys to Patient Counseling and Guidance08/24/2017
    Roles of Non-HDL Cholesterol in Risk Assessment and Treatment09/19/2017
    Keys to the Latest NLA Recommendations for Dyslipidemia Treatments09/14/2017
    Management of the Patient With Triglycerides 200-499 mg/dl.09/21/2017
    What is the Safety of Statins in Patients with Diabetes?09/27/2017
    A Synopsis of the ACC/AHA Risk Assessment and Cholesterol Guidelines11/20/2017
    National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia05/29/2015
    New Insights on Statin Therapy for Older Patients10/05/2017
    HPS-2 THRIVE Data and Results10/19/2017
    Health Information Technology's Impact on Adherence to Lipid Therapy10/10/2017
    Cardiometabolic Consequences of Sitting Time03/17/2016
    Generics and Manufacturing: What Prescribers Need to Know10/26/2017
    Genetic Testing for Familial Hypercholesterolemia01/08/2016
    Research Updates in Familial Hypercholesterolemia02/24/2016
    Research Updates on Postprandial Dyslipidemia Treatment02/25/2016
    Lipid Biomarker Updates: When to Move Beyond the Standard Profile02/25/2016
    What is HoFH: Detection and Management of the Homozygous Familial Hypercholesterolemia (HoFH) Pat...10/13/2015
    Adiposity, Obesity, and Dyslipidemia02/18/2016
    Researching Oxidized High-Density Lipoprotein in Obese Adolescents08/29/2016
    Underrecognition of Diabetes in Cardiology Practice02/19/2016
    An Avocado a Day: Does It Keep Heart Disease Away?02/26/2016
    The Impact of Inflammation on HDL Activity09/27/2016
    Changing Nutritional Needs Throughout the Lifetime11/19/2015
    Managing CVD in Women During Childbearing Years09/03/2015
    Obesity, Diabetes and the Metabolic Syndrome03/06/2015
    Broken Hearts or Broken Bones?11/17/2015
    Non-pharmacologic Approaches to the Metabolic Syndrome and Diabetes09/25/2015
    Evolving Treatments: A Review of What’s in the Pipeline06/14/2013
    Fish Oils: Are They Still Cardioprotective?07/05/2013
    Treatment Options for Polycystic Ovarian Syndrome (PCOS)12/01/2017
    Controversy Surrounding the NHLBI Pediatric Guidelines04/03/2015
    Statin Safety Considerations08/23/2013
    Emerging LDL Therapies04/10/2015
    Emerging HDL Therapies: What’s Next on the Clinical Research Horizon03/20/2015
    Understanding Why Patients Discontinue Statin Therapy05/08/2015
    Statin Therapy and Diabetes Incidence08/28/2015
    Lipids and Hormone Therapy03/01/2013
    Diet Controversies in Lipid Lowering & Cardiovascular Disease Prevention02/22/2013
    Biomarkers and Lipidology03/08/2013
    Diagnosis, Prevalence, and Screening of Familial Hypercholesterolemia02/15/2013
    Fat, Exercise and Cholesterol11/08/2017
    Managing Lipids in the Chronic Kidney Disease Patient11/23/2017
    Coronary CT Angiography08/16/2013
    Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease07/12/2013
    Management Issues in Familial Hypercholesterolemia09/29/2016
    Familial Hypercholesterolemia: Risk Stratifications in Practice09/20/2013
    From Experts to Analytics: What Does Evidence-Based Medicine Mean?01/25/2013
    CIMT Appropriate Use Guidelines08/09/2013
    Personalizing Dietary Approaches for Cardiovascular Health08/02/2013
    LDL Apheresis10/04/2016
    Imaging Guidelines for Screening CV Risk06/15/2012
    Fundamentals of Fatty Acids06/08/2012
    It's Relative: Screening and Treating Familial Hypercholesterolemia06/22/2012
    Caring for Un- and Under-Insured Patients on Lipid Therapy09/13/2016
    Current Inquiries in Lipidology: The NLA's Role in the Field06/03/2011
    Predictive Value of Lipid Biomarkers and Inflammatory Markers05/06/2011
    The Importance of Omega-3 Fatty Acids04/29/2011
    Metabolic Syndrome in African Americans: Risk Adjustments & Treatments04/22/2011
    Atherosclerosis and Cardiovascular Risk Factors in Children04/15/2011
    Cardiometabolic Risk Reduction in Native Americans04/01/2011
    The Process of Developing Clinical Guidelines10/08/2010
    Updates on the ACCORD Trial From the 2010 National Lipid Association Meeting10/01/2010
    Lipid Management and Systemic Approaches to Patient Care09/10/2010
    Heart Disease in the United States: Past, Present, and Future Trends10/15/2010
    Behavioral Strategies for Managing Weight03/11/2011
    Exercise as Medicine03/25/2011
    Using HDL in the Clinical Setting12/24/2010
    Particle Number Testing in the Prevention of Atherosclerosis03/26/2010
    Strategies to Help Reduce Diseases Associated with Lifestyle03/25/2016
    Reevaluating Heart Protective vs Destructive Dietary Fats03/04/2011
    Dietary Fats and Cardiovascular Disease08/20/2010
    Looking Beyond LDL to Reduce Cardiovascular Events11/02/2008
    The Latest Targets of Lipid Therapy09/07/2008

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.